The Lifetime Prevalence and Factors Associated with Relapse Among Mentally Ill Patients at Jimma University Medical Center, Ethiopia: Cross Sectional Study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Metrics GH. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Psychiatry. 2018;392:1990–2017.
World Health Organization, Geneva, 2011.
Grace R, Onaiza Q, Natasha SJE. Mental health for global prosperity. London Sch Hyg Trop Med. 2019;(January):1–3.
Kazadi NJB, Moosa MYH, Jeenah FY. Articles factors associated with relapse in schizophrenia. Soc Anxiety J Psychiatry. 2008;14(2):52–3.
Doering S, Mutter E, Kopcke W, Pietzcker A, Qaebel W, Linden M, et al. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull. 1998;24(1):87–98.
Dunn T. The association between medication adherence in mental illness and substance use disorder relapse in patients with dual diagnosis. Subst Abuse Addict J 2018; 100–105.
Vaughn BCE. The influence of family and social factors on the course of psychiatric illness. Br J Psychiatry. 1976;129:125–37.
Baguma C, Ashaba S. Portrayals of mental illness, treatment, and relapse and their effects on the stigma of mental illness: population-based, randomized survey experiment in rural Uganda. PLoS ONE Med. 2018;4:1–19. https://doi.org/10.1371/journal.pmed.1002908.
Rollins AL, O’Neill SJ, Davis KE, Devitt TS. Substance abuse relapse and factors associated with relapse in an inner-city sample of patients with dual diagnoses. Psychiatr Serv. 2005;56(10):1274–81.
Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse. Arch Gen Psychiatry. 1998;55(6):547–52.
Di S, Rachel C, Mallikarjun P. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication. Early Interv Psychiatry. 2018;12(5):893–9. https://doi.org/10.1111/eip.12385Epub 2016 Oct 13.
Hayes JF, Osborn DPJ, Lundin A, Dalman C. Psychiatric hospitalization following antipsychotic medication cessation in first-episode psychosis. J Psychopharmacol. 2019;33(4):532–4. https://doi.org/10.1177/0269881119827883.
Camacho-Gomez M, Castellvi P. Effectiveness of family intervention for preventing relapse in first-episode psychosis until 24 months of follow-up: a systematic review with meta-analysis of randomized controlled trials. Schizophr Bull. 2018;46(1):98–109. https://doi.org/10.1093/schbul/sbz038.
Takeuchi H, Siu C, Remington G, Fervaha G, Zipursky RB, Foussias G. Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. Second-episode schizophrenia. Neuropsychopharmacology. 2018;2:1–7. https://doi.org/10.1038/s41386-018-0278-3.
Curto M, Masters G, Girardi P. Factors associated with costs of hospitalization of severely mentally ill bipolar disorder: open access factors associated with costs of hospitalization of severely mentally ill patients. J Bipolar Disord. 2016;2:1–4.
Thomas P. Relapse: causes and consequences. Encephale J. 2013;39:S79–82. https://doi.org/10.1016/S0013-7006(13)70100-3.
C-h T. One-year post-hospital medical costs and relapse rates of bipolar disorder patients in Taiwan: a population-based study. Bipolar Disord. 2010;12(8):859–65. https://doi.org/10.1111/j.1399-5618.2010.00878.
Rice S, Gleeson J, Davey C, Hetrick S, Parker A, Lederman R, et al. Original article moderated online social therapy for depression relapse prevention in young people: a pilot study of a ‘ next generation ‘ online intervention. Early Interv Psychiatry. 2018;12:613–25.
Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Alexopoulos GS, Rudorfer MV, et al. Effect of continuing olanzapine vs placebo on relapse among patients with psychotic depression in remission the STOP-PD II randomized clinical trial. JAMA Psychiatry. 2019;322(7):622–31.
Johnson S, Lamb D, Marston L, Osborn D, Mason O, Henderson C, et al. Peer-supported self-management for people discharged from a mental health crisis team: a randomized controlled trial. Lancet. 2018;392(10145):409–18. https://doi.org/10.1016/S0140-6736(18)31470-3.
Ayano G, Duko B. Relapse, and hospitalization in patients with schizophrenia and bipolar disorder at the St Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia: a comparative quantitative cross-sectional study. Neuropsychiatr Dis Treat. 2017;13:1527–31.
Habtamu K, Medhin G, Selamu M, Tirfessa K, Hanlon C. Functional impairment among people diagnosed with depression in primary healthcare in rural Ethiopia: a comparative cross-sectional study. Int J Ment Health Syst. 2019. https://doi.org/10.1186/s13033-019-0305-8.
Goleman D, Boyatzis R, Mckee A. Depression self-stigma as a mediator of the relationship between depression severity and avoidance. J Chem Inf Model. 2019;53(9):1689–99.
Girma E, Tesfaye M, Froeschl G, Möller-Leimkühler AM, Dehning S, Müller N. Facility based cross-sectional study of self-stigma among people with mental illness: towards patient empowerment approach. Int J Ment Health Syst. 2013;7(21):1–8. https://doi.org/10.1186/1752-4458-7-21.
Tanabe Y, Hayashi K, Ideno Y. The internalized stigma of mental illness (ISMI) scale: validation of the Japanese version. BMC Psychiatry. 2016. https://doi.org/10.1186/s12888-016-0825-6.
Abiola T, Udofia O, Zakari M. Psychometric properties of the 3-item Oslo social support scale among clinical students of Bayero University Kano, Nigeria. Malays J Psychiatry. 2013;22:32–41.
Group WAW. The alcohol, smoking, and substance involvement screening test (ASSIST): development, reliability and feasibility. Addict J Psychiatry. 2002;97:1183–94.
Morken G, Widen JH, Grawe RW. Rehospitalisation in recent-onset schizophrenia. BMC Psychiatry. 2008;7(8):1–7.
Arlington. Diagnostic and statistical manual of mental disorders. America; 2013, pp 153–67.
Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder. Arch Gen Psychiatry. 2003;60:145–52.
Fikreyesus M, Soboka M, Feyissa GT. Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study. BMC Psychiatry. 2016;16(354):5–7. https://doi.org/10.1186/s12888-016-1076-2.
Weret ZS, Mukherjee R. Prevalence of relapse and associated factors in patient with schizophrenia at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia: institution based cross-sectional study. Int J Interdiscip Multidiscip Stud. 2014;2(1):184–92.
Fekadu A, Kebede D, Alem A, Fekadu D, Mogga S, Negash A, et al. Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira, Ethiopia. Acta Psychiatry Scand. 2006;114:426–34.
Gopinath S, Katon WJ, Russo JE, Ludman EJ. Clinical factors associated with relapse in primary care patients with chronic or recurrent depression. J Affect Disord. 2007;101(3):57–63.
Schoeler T, Petros N, Di Forti M, Klamerus E, Foglia E, Murray R, et al. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis. Lancet Psychiatry. 2017;4(8):627–33. https://doi.org/10.1016/S2215-0366(17)30233-X.
Chaurotia VK, Verma KK, Baniya GC. A study of psychosocial factor related with relapse in schizophrenia. J Dent Med Sci. 2016;15(4):26–34.
Yassin S, Ali AA. Predictors of non-adherence in patients taking psychotropic medication and predictors of non-adherence in patients taking psychotropic medication and suggestions to improve. J Heal Med Nurs. 2019;38:73–5.
Hosman J-L& S. Prevention of Mental Disorders Geneva; 2005.
Wessel H, Wenaas M, Nordfjærn T. Addictive behaviors relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances. Addict Behav. 2019;90:222–8. https://doi.org/10.1016/j.addbeh.2018.11.008.
Werbeloff N, Chang C, Broadbent M, Hayes JF, Stewart R, Osborn DPJ. Admission to acute mental health services after contact with crisis resolution and home treatment teams: an investigation in two large mental health-care providers. Lancet Psychiatry. 2015;4(1):49–56. https://doi.org/10.1016/S2215-0366(16)30416-3.